with Nuclear Pharmacy Services
Thank you for connecting with us.
Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.
Please fill out this field

Radiopharmaceutical commercialization support

Developing new radiopharmaceuticals takes commitment of both time and resources. To give your new product its best chance of success, you need a partner who is just as committed to nuclear medicine. Cardinal Health, leader in the radiopharmaceutical industry with 40 years of experience, 133 nuclear pharmacies, and 34 strategically located PET manufacturing facilities, is your partner of choice. We have the reach and scale to enable efficient commercialization of your radiopharmaceutical.

Pre-commercialization support

Cardinal Health has the industry knowledge, extensive network and unmatched quality to support your radiopharmaceutical from clinical development and trials to commercialization.

Commercialization support

Cardinal Health has a strong legacy of helping innovators bring new and novel radiopharmaceuticals to market that diagnose and treat diseases that are the leading cause of death.